Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MIF | P14174 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9672470 | 0.80 | TAAR1 (0.53) | CYP3A4CYP1A2MAPTALDH1A1CYP2D6 | |
| SCHEMBL21154355 | 0.80 | CALM1 (0.54) | CYP3A4MAPTALDH1A1HPGDCYP2D6 | |
| SCHEMBL109195 | 0.80 | TAAR1 (0.64) | CYP3A4CYP1A2MAPTALDH1A1CYP2D6 | |
| SCHEMBL1422874 | 0.79 | ALDH1A1 (0.58) | CYP3A4CYP1A2MAPTALDH1A1HPGD | |
| SCHEMBL108109 | 0.78 | TAAR1 (0.62) | CYP3A4CYP1A2MAPTALDH1A1CYP2D6 | |
| SCHEMBL9391810 | 0.78 | CYP1A2 (0.49) | CYP3A4CYP1A2MAPTCYP2D6TAAR1 | |
| SCHEMBL7144056 | 0.78 | KMT2A (0.62) | CYP3A4CYP1A2MAPTALDH1A1TAAR1 | |
| Hydrochloric Acid SCHEMBL4942544 | 0.77 | ALDH1A1 (0.56) | CYP3A4CYP1A2MAPTALDH1A1HPGD | |
| SCHEMBL108065 | 0.77 | CALM1 (0.62) | CYP3A4CYP1A2MAPTALDH1A1HPGD | |
| SCHEMBL31621161 | 0.77 | CALM1 (0.50) | CYP3A4CYP1A2MAPTALDH1A1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111087305-A | β -fluoroalkyl cinnamate compound and preparation method thereof | 南京工业大学 | 2020-05-01 | — | — | CN | claimed |
| EP-0832887-B1 | N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug | SHISEIDO CO LTD (JP) | 2001-08-08 | — | — | EP | claimed |
| CN-111087305-B | Beta-fluoroalkyl cinnamate compound and preparation method thereof | 南京工业大学 | 2021-08-27 | — | — | CN | disclosed |
| CN-111087305-A | β -fluoroalkyl cinnamate compound and preparation method thereof | 南京工业大学 | 2020-05-01 | — | — | CN | disclosed |
| US-6673772-B2 | INHIBITING THE ENZYMATIC ACTIVITY OF HIV PROTEASE | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2004-01-06 | — | — | US | disclosed |
| US-20020049165-A1 | Novel dipeptide compounds and their use as medicines | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2002-04-25 | — | — | US | disclosed |
| EP-1157997-A1 | NOVEL DIPEPTIDE COMPOUND AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2001-11-28 | — | — | EP | disclosed |
| EP-0832887-B1 | N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug | SHISEIDO CO LTD (JP) | 2001-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049165-A1 | Novel dipeptide compounds and their use as medicines | DNPEP, PEPD, ANPEP | CYP3A4 781/4885CYP1A2 3118/4885MAPT 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.